FI934366A0 - Atp-analoger - Google Patents

Atp-analoger

Info

Publication number
FI934366A0
FI934366A0 FI934366A FI934366A FI934366A0 FI 934366 A0 FI934366 A0 FI 934366A0 FI 934366 A FI934366 A FI 934366A FI 934366 A FI934366 A FI 934366A FI 934366 A0 FI934366 A0 FI 934366A0
Authority
FI
Finland
Prior art keywords
alkyl
alkoxy
halogen
aryl
optionally substituted
Prior art date
Application number
FI934366A
Other languages
English (en)
Finnish (fi)
Other versions
FI934366L (fi
FI934366A7 (fi
Inventor
Anthony Howard Ingall
Peter Alan Cage
Original Assignee
Fisons Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919107236A external-priority patent/GB9107236D0/en
Priority claimed from GB919123671A external-priority patent/GB9123671D0/en
Application filed by Fisons Plc filed Critical Fisons Plc
Publication of FI934366L publication Critical patent/FI934366L/fi
Publication of FI934366A0 publication Critical patent/FI934366A0/fi
Publication of FI934366A7 publication Critical patent/FI934366A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3808—Acyclic saturated acids which can have further substituents on alkyl
    • C07F9/3821—Acyclic saturated acids which can have further substituents on alkyl substituted by B, Si, P or a metal
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Color Television Image Signal Generators (AREA)
FI934366A 1991-04-06 1992-04-02 ATP-analogit FI934366A7 (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB919107236A GB9107236D0 (en) 1991-04-06 1991-04-06 Compounds
GB919123671A GB9123671D0 (en) 1991-11-07 1991-11-07 Compounds
PCT/GB1992/000590 WO1992017488A1 (fr) 1991-04-06 1992-04-02 Analogues d'atp

Publications (3)

Publication Number Publication Date
FI934366L FI934366L (fi) 1993-10-05
FI934366A0 true FI934366A0 (fi) 1993-10-05
FI934366A7 FI934366A7 (fi) 1993-10-05

Family

ID=26298696

Family Applications (1)

Application Number Title Priority Date Filing Date
FI934366A FI934366A7 (fi) 1991-04-06 1992-04-02 ATP-analogit

Country Status (18)

Country Link
EP (2) EP0508687B1 (fr)
JP (1) JP3141028B2 (fr)
CN (2) CN1031879C (fr)
AT (1) ATE127808T1 (fr)
CA (1) CA2107667A1 (fr)
DE (1) DE69204717T2 (fr)
DK (1) DK0508687T3 (fr)
ES (1) ES2078654T3 (fr)
FI (1) FI934366A7 (fr)
GR (1) GR3018307T3 (fr)
HU (2) HUT64967A (fr)
IE (1) IE921091A1 (fr)
IL (1) IL101485A0 (fr)
MX (1) MX9201577A (fr)
NO (1) NO933555L (fr)
NZ (1) NZ242243A (fr)
PL (1) PL297372A1 (fr)
WO (1) WO1992017488A1 (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5760021A (en) * 1992-05-29 1998-06-02 The Procter & Gamble Company Phosphonocarboxylate compounds pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism
US5731299A (en) * 1992-05-29 1998-03-24 The Procter & Gamble Company Phosphonosulfonate compounds, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism
SK281309B6 (sk) * 1993-02-10 2001-02-12 Astra Pharmaceuticals Limited N-alkyl-2-substituované adenozíntrifosfátové deriváty, spôsob ich prípravy, farmaceutické prostriedky obsahujúce tieto deriváty a použitie týchto derivátov
FR2721929B1 (fr) * 1994-06-30 1996-12-20 Centre Nat Rech Scient Analogues stables, non hydrolysables, de diphosphates et leurs procedes de preparation
WO1998018430A2 (fr) * 1996-10-30 1998-05-07 The University Of North Carolina At Chapel Hill Antagonistes des recepteurs p2y
US6159952A (en) * 1996-11-07 2000-12-12 Inspire Pharmaceuticals, Inc. Method of treating bronchitis with uridine triphosphate and related compounds
US6686462B2 (en) * 1997-02-28 2004-02-03 The Regents Of The University Of California Antiviral compounds and methods of administration
FI104901B (fi) 1997-10-20 2000-04-28 Leiras Oy Uudet metyleenibisfosfonihappojohdannaiset
US6667306B1 (en) 1998-01-15 2003-12-23 Millennium Pharmaceuticals, Inc. Platelet ADP receptor inhibitors
TWI229674B (en) 1998-12-04 2005-03-21 Astra Pharma Prod Novel triazolo[4,5-d]pyrimidine compounds, pharmaceutical composition containing the same, their process for preparation and uses
IL147194A0 (en) * 1999-06-22 2002-08-14 Cv Therapeutics Inc Thiophene a2a receptor agonists
SE9903290D0 (sv) * 1999-09-15 1999-09-15 Astra Pharma Prod Novel compounds
SE9904377D0 (sv) * 1999-12-01 1999-12-01 Astra Pharma Prod Pharmaceutical combinations
GB0013488D0 (en) * 2000-06-02 2000-07-26 Astrazeneca Ab Chemical compound
US7115585B2 (en) 2000-08-21 2006-10-03 Inspire Pharmaceuticals, Inc. Compositions for treating epithelial and retinal tissue diseases
US7018985B1 (en) 2000-08-21 2006-03-28 Inspire Pharmaceuticals, Inc. Composition and method for inhibiting platelet aggregation
US7452870B2 (en) 2000-08-21 2008-11-18 Inspire Pharmaceuticals, Inc. Drug-eluting stents coated with P2Y12 receptor antagonist compound
US7132408B2 (en) 2000-08-21 2006-11-07 Inspire Pharmaceuticals, Inc. Composition and method for inhibiting platelet aggregation
US6897201B2 (en) 2000-08-21 2005-05-24 Inspire Pharmaceuticals, Inc. Compositions and methods for the treatment of glaucoma or ocular hypertension
US7435724B2 (en) 2002-02-27 2008-10-14 Inspire Pharmaceutical, Inc. Degradation-resistant mononucleoside phosphate compounds
SE0401001D0 (sv) 2004-03-31 2004-03-31 Astrazeneca Ab Chemical process
EP2021350B1 (fr) * 2006-03-21 2016-12-21 Rheinische Friedrich-Wilhelms-Universität Bonn Agonistes du récepteur a2a phosphorylé
EP2669292B1 (fr) 2011-01-26 2017-03-29 Beijing KBD Pharmaceuticals Co., Ltd. Composés de ribofuranosyl-purine pour le traitement des maladies associées à l'agrégation plaquettaire
CN102659691B (zh) * 2012-05-23 2014-04-02 山东诚创医药技术开发有限公司 一种4,6-二氯-5-氨基-2-丙硫基嘧啶的制备方法
CN103288748A (zh) * 2013-06-21 2013-09-11 四川铂瑞生物医药有限公司 一种4.6-二氯-5-氨基-2-丙硫基嘧啶的制备方法
CN104003943A (zh) * 2014-05-06 2014-08-27 南通常佑药业科技有限公司 一种替格瑞洛中间体的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990011080A1 (fr) * 1989-03-24 1990-10-04 Daiichi Pharmaceutical Co., Ltd. Medicament ameliorant les fonctions cerebrales

Also Published As

Publication number Publication date
GR3018307T3 (en) 1996-03-31
EP0579643A1 (fr) 1994-01-26
ATE127808T1 (de) 1995-09-15
IL101485A0 (en) 1992-12-30
MX9201577A (es) 1992-10-01
HUT64967A (en) 1994-03-28
WO1992017488A1 (fr) 1992-10-15
HU211334A9 (en) 1995-11-28
IE921091A1 (en) 1992-10-07
CN1068574A (zh) 1993-02-03
CN1031879C (zh) 1996-05-29
PL297372A1 (en) 1993-09-06
EP0508687A1 (fr) 1992-10-14
AU1451992A (en) 1992-11-02
NZ242243A (en) 1993-06-25
ES2078654T3 (es) 1995-12-16
JPH06505987A (ja) 1994-07-07
FI934366L (fi) 1993-10-05
DE69204717T2 (de) 1996-04-25
EP0508687B1 (fr) 1995-09-13
CN1120936A (zh) 1996-04-24
DE69204717D1 (de) 1995-10-19
NO933555D0 (no) 1993-10-05
CA2107667A1 (fr) 1992-10-07
FI934366A7 (fi) 1993-10-05
AU648885B2 (en) 1994-05-05
JP3141028B2 (ja) 2001-03-05
NO933555L (no) 1993-10-05
HU9302812D0 (en) 1993-12-28
DK0508687T3 (da) 1996-02-05

Similar Documents

Publication Publication Date Title
ATE127808T1 (de) Atp-analogen.
FI104172B1 (fi) Herbisidiset 4-bentsoyyli-isoksatsolijohdannaiset
DE69028136D1 (de) Alkoxyiminoacetamid-Derivate und ihre Verwendung als pilztötendes Mittel
IL113313A0 (en) Heterocyclic compounds and pharmaceutical compositions containing the same
ATE18048T1 (de) Carbapenem-derivate, ihre herstellung und sie enthaltende zusammensetzungen.
MY131297A (en) Herbicides
DE69331843D1 (de) Xanthine-Derivate als Antidepressiva
ATE144772T1 (de) Piperazinderivate
ES474215A1 (es) Procedimiento para la preparacion de derivados imidazolile- tiloxialcoxilicos y sus analogos con agrupacion tio
NO921159L (no) Tiazolidinon- og oksazolidinonderivater, fremgangsmaate til fremstilling derav, samt anvendelse av derivatene som vasodilatorer
DE58908577D1 (de) Heterocyclisch substituierte Alkyl- und Alkenylsulfonylharnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung als Herbizide oder Pflanzenwachstumsregulatoren.
AU4271389A (en) Phenylalkyl or phenylalkoxyethyl substituted piperazine derivatives
DE69326479D1 (de) Methotrexat-derivate
FI860145A0 (fi) Herbicider av typ n-(fosfonometylglycyl)sulfonylaminer.
ATE98645T1 (de) Heterocyclisch substituierte n-sultamsulfonamide, verfahren zu ihrer herstellung und ihre verwendung als herbizide und pflanzenwachstumsregulatoren.
ES8802413A1 (es) Procedimiento para preparar una composicion herbicida a base de carbamoiloxi-fenilcarbamato y aceite mineral de petroleo
DE69208384D1 (de) Fungizide Furanonderivate
BR9305092A (pt) Processo para a preparação de derivados de 5-pirazolmercáptan, composto ditiocarbazato de etilideno, processo para a preparação de derivados do mesmo
DE68905222D1 (de) 7-(1-imidazolyl)-1,4-dihydro-4-oxo-6,8-difluoro-1-cyclopropylchinolincarbonsaeure-derivate, ihre herstellung und ihre verwendung als arzneimittel.
ATE268769T1 (de) Pyrimidinderivate mit antitumor-wirkung

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: ASTRA PHARMACEUTICALS LIMITED

FD Application lapsed